Clinical Trial

Higher and Standard Doses of Enteral Zinc Supplementation in Very Preterm Infants

Study acronym: ZnVeryPT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this randomized clinical trial is to compare the effect of higher (10 mg per day) versus standard (1 mg per day) doses of zinc supplementation The main questions it aims to answer are: * Growth velocities and delta z-scores during the date of start intervention until the end of the time interval (at least 2 weeks of intervention on date of 44 weeks of postmenstrual age or discharge whichever came first) in very preterm infants with a birthweight less than1800 grams. * Growth and neurodevelopment at 24 months postnatal age
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-12; most recent amendment 2024-09-14.
Status change: Enrolling by Invitation → Recruiting 2024-09-14
Trial Details
NCT Number NCT06219525
Lead Sponsor Prince of Songkla University
Conditions Very Preterm Infants, Zinc Deficiency
Enrollment 120 participants
Start Date 2024-04-02
Primary Completion 2025-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-09-19